| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |